FIELD: medicine.
SUBSTANCE: invention refers to medicine and may be used for relieving abdominal murmur. That is ensured by the oral administration of the bacteria Bifidobacterium animalis in dose 1×109 CFU a day. The bacteria are administered every day, for at least 15 days.
EFFECT: method provides relieving abdominal murmur in a healthy individual that is ensured by the developed dose schedule and specific rate of administration of the above prebiotic.
10 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR REDUCING ABDOMINAL GIRTH BY ADMINISTERING BACTERIA BIFIDOBACTERIUM | 2008 |
|
RU2491946C2 |
COMPOSITION FOR REDUCING INTESTINAL GAS PRODUCTION | 2015 |
|
RU2725883C2 |
USING LACTOBACILLUS PARACASEI CNCM I-2116 TO TREAT IRRITABLE BOWEL SYNDROME | 2003 |
|
RU2490325C2 |
PROBIOTICS FOR INTESTINE NEUROMUSCULAR FUNCTION | 2003 |
|
RU2346036C2 |
COMBINATION OF LACTOBACTERIA FOR RELIEF OF IRRITABLE BOWEL SYNDROME AND FOR RELIEF OF OTHER GASTROINTESTINAL DISORDERS | 2019 |
|
RU2809845C2 |
NON-VIABLE BACTERIA BIFIDOBACTERIUM BIFIDUM AND THEIR USE | 2019 |
|
RU2800878C2 |
BIFIDOBACTERIA FOR REDUCING FOOD, ENERGY AND/OR FAT CONSUMPTION | 2017 |
|
RU2762096C2 |
BIFIDOBACTERIA FOR INCREASING FAT-FREE BODY WEIGHT | 2017 |
|
RU2757213C2 |
USE OF COMPOSITIONS CONTAINING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS LMG P-28149 | 2015 |
|
RU2673341C2 |
PROBIOTIC BACTERIA PRE-CONDITIONED IN GOS-CONTAINING MEDIUM, AND USE THEREOF | 2018 |
|
RU2819273C2 |
Authors
Dates
2013-09-20—Published
2009-05-26—Filed